期刊文献+

肝硬化患者血浆凝血因子的研究 被引量:3

The Research on Plasma Coagulation Factor of Patients with Cirrhosis
暂未订购
导出
摘要 目的:系列检测50例肝硬化患者血浆凝血因子,分代偿期与失代偿期两组,并分别探索其临床意义。方法:凝血因子抗原测定采取火箭电泳法,凝血因子活性测定采取一期凝血法或发色底物法。结果:除凝血因子Ⅶ活性升高外,其余各凝血因子的抗原性与活性均呈不同程度的降低。其中失代偿期因子Ⅴ与纤维蛋白原的降低显著。结论:因子Ⅴ降低见于肝硬化失代偿期,其降低表明病情恶化与预后不良。 Purpose: The concertration of coagulation factors is detected in 50 patients with cirrhosis (the cases are divided to compensatory phase and decompensatory phase) , which clinical significance is discussed. Methods: Antigens of coagulation factors are detected with rocket electrophoresis method. Activity of coagulation factors is detected with one clotting stage way or chromogenic peptide substrate method. Results: The activity of factor 1/1 was elevated, the antigens and activity of other coagulation factors are decreased and amongst decreasing of FV and fibrinogen only can be seen in decompensatory phase of cirrhosis. GDnclusion: Hemostatic disturbance may be caused by the decrease of antigens and activity of every coagulation factor in patients with cirrhosis. Whereas activity of FW is elevated, it may be the risk factors of venous thrombosis. The decrease of fibrinogen and F V are seen in decompenstaory phase of cirrhosis, which indicated exacerbation of the condition and bad prognosis of cirrhosis patients.
出处 《临床消化病杂志》 2002年第4期171-172,共2页 Chinese Journal of Clinical Gastroenterology
关键词 肝硬化 代偿期 失代偿期 凝血因子 Hepatic cirrhosis Compensatory phase Decompensatory phase Coagulation factor
  • 相关文献

参考文献2

二级参考文献7

  • 1[1]Teufelsbauer H, Proidl S, Havel M, et al. Early activation of hemostasis during cardiopulminary bypass: evidence for thrombin mediated hyperfibrinolysis. Thromb Haemost, 1992, 68(3): 250-252.
  • 2[2]Dayal S, Pati HP, Sharna MP, et al. Tissue plasminogen activator and plasminogen activator inhibitor status in Budd-Chiari syndrome.Haemostasis, 1996, 26 (5): 284-287.
  • 3[3]Huber K, Kirchheimer JC, Koringer C, et al. Hepatic synthesis and clearance of components of the fibrinolytic system in healthy volunteersand in patients with different stages of liver cirrhosis. Throm Res,1991,62: 491-500.
  • 4[6]Ben AZ, Panagou M, Patch D, et al. Hypercoagulability in patients with primary biliary cirrhosis and primary sclerosing cholangitis evaluated by thrombelastography. J Hepatol, 1997, 26(3): 554-559.
  • 5[7]Sehetz MR. Coagulation disorders in acute renal failure. Kidney Int Suppl, 1998, 66: 96-101.
  • 6[8]Okajima K. Clinical revelevance of determination of plasma AT Ⅲ and α2 antiplasmin activities in patients with DIC application of the molecularmarkers for the analysis of pathophysiology of DIC. Rinsho Byori,1994, 42 (1): 45-55.
  • 7[9]Rocha E, Paramo JA, Montes R, et al. Acute generalized, widespread bleeding. Diagnosis and management. Haematologica, 1998, 83 ( 11 ):1024-1037.

共引文献68

同被引文献23

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部